NCT03783325 is a NA clinical trial of UV Counseling in Nevi and Melanomas, sponsored by University of Colorado, Denver.

Who is sponsoring NCT03783325?

NCT03783325 is sponsored by University of Colorado, Denver.

What drugs are being tested in NCT03783325?

Interventions in NCT03783325: UV Counseling, UV Photo, Biological Sample.

What condition does NCT03783325 study?

NCT03783325 studies Nevi and Melanomas.

Is NCT03783325 still recruiting?

NCT03783325 is currently completed. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT03783325

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Gene-Environment Interactions in Clinical Presentation of Nevi and Melanoma

Completed NA Last updated 23 October 2023

What this trial tests

NA trial testing UV Counseling in Nevi and Melanomas in 71 participants. Completed in 17 June 2022.

Timeline

17 February 2017

Primary endpoint
17 June 2022

17 June 2022

Quick facts

Lead sponsor	University of Colorado, Denver
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	71
Start date	17 February 2017
Primary completion	17 June 2022
Estimated completion	17 June 2022
Sites	1 location across United States

Drugs / interventions tested

UV Counseling
UV Photo
Biological Sample — full drug profile →

Conditions studied

Nevi and Melanomas — all drugs for Nevi and Melanomas →

Sponsor

University of Colorado, Denver

Who can join

18 and older, any sex, with Nevi and Melanomas. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research study is designed to better understand the role of genetics, sun-exposure and phenotypic factors in melanoma.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of UV Counseling

Trials testing the same drug.

NCT03757663 — UV Dosimetry Feedback in NMSC Patients · NA · withdrawn

Other recruiting trials for Nevi and Melanomas

Currently open trials in the same condition.

NCT06605443 — Precision Medicine for L/GCMN and Melanoma 2 · recruiting
NCT06608420 — Precision Medicine for L/GCMN and Melanoma 1 · recruiting
NCT06605417 — Understanding the Transition from Normal Melanocytes to Nevus to Melanoma · recruiting

Other University of Colorado, Denver trials

Trials by the same sponsor.

NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03783325 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03783325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing